Microalgal carotenoids

01Overview and value chain#

Markers EC: EU Novel Food & FDA DSHEA dietary-supplement rules | OECD: Marine bioeconomy | Regulator: FDA (USA), EFSA (EU), NMPA (China)

Microalgal carotenoids are the high-value pigments microalgae accumulate under stress — chiefly natural astaxanthin from Haematococcus pluvialis and natural beta-carotene from Dunaliella salina. Cyanotech runs a 96-acre cultivation farm on Hawaii’s Kona Coast with more than 40 years of microalgae experience; Algalíf in Iceland markets the Astalíf™ oleoresin line at 5%, 10%, 15% and 20% astaxanthin, having launched the world’s first 15% oleoresin and, in April 2026, the Astalíf™ 20 benchmark; BDI-BioLife Science produces ASTAFIT® astaxanthin “Made in Austria”; and Cyanotech’s BioAstin® is sold at an industry-leading 12 mg of Hawaiian astaxanthin per serving. The value is the antioxidant potency and pigment purity of microalgae-grown carotenoids, sold as B2B oleoresins and finished supplements.

The key directions of microalgal carotenoids are:

1. Haematococcus astaxanthin (Haematococcus Astaxanthin): two-stage cultivation of Haematococcus pluvialis (green growth → red cyst stress) yielding natural astaxanthin (Cyanotech BioAstin, BDI ASTAFIT, Algalíf Astalíf).
2. Dunaliella beta-carotene (Dunaliella Beta-Carotene): high-salinity open-pond cultivation of Dunaliella salina for natural beta-carotene (all-trans / 9-cis mix).
3. High-concentration oleoresins (Astaxanthin Oleoresin): supercritical-CO₂ extraction and standardization to 5–20% astaxanthin oleoresins (Algalíf Astalíf™ 5/10/15/20, world’s first 15% and 20% benchmarks).
4. Controlled microalgae cultivation (Microalgae Photobioreactor): closed photobioreactor and raceway cultivation using Iceland geothermal energy and Hawaiian/Kona coastal conditions for reproducible carotenoid content.

Sectoral value chain#

[microalga strain (Haematococcus / Dunaliella)] ──> [green-cell cultivation] ──> [stress induction (astaxanthin)]
                                                          │
                                                  (light / N-starvation)
                                                          │
                                                          ▼
[5–20% oleoresin + supplement] <─── [supercritical CO₂ extraction] <─────┘

Value chain levels#

Cross-cutting technologies of the sector:

• Two-stage Haematococcus cultivation (Two-Stage Haematococcus Cultivation): separated green-growth and red-induction phases for high astaxanthin yield.
• Supercritical CO₂ extraction (Supercritical CO₂ Extraction): solvent-free recovery of carotenoid oleoresin at food-grade purity.
• Geothermal / tropical cultivation siting (Geothermal / Tropical Siting): Iceland geothermal energy (Algalíf) and Hawaiian coastal climate (Cyanotech) for low-cost controlled cultivation.

02US#

The United States anchors natural astaxanthin production through its long-established Hawaiian microalgae industry.

Cyanotech Kona farm, Nutrex Hawaii, university microalgae research#

• Cyanotech (Hawaii): a world leader in microalgae-based nutrition, operating a 96-acre farm on Hawaii’s Kona Coast with more than 40 years of cultivation experience; its BioAstin® Hawaiian Astaxanthin® is a leading natural astaxanthin brand, sold via its Nutrex Hawaii subsidiary (a 12 mg-per-serving gummy format launched in 2024) and quoted OTCQB:CYAN.
• University microalgae research: US universities (e.g. UC San Diego, Arizona State) underpin the strain-engineering and physiology science base for Haematococcus astaxanthin accumulation.
• Dietary-supplement market: the US DSHEA framework anchors the largest natural-astaxanthin supplement market, driving finished-format innovation (softgels, gummies).

03CN#

China is a large and fast-growing producer of natural astaxanthin, but the two leading candidate firms could not be source-confirmed against a 2026 live source within the capped search, so this block is qualitative.

Domestic Haematococcus cultivation, Yunnan and Hubei regions#

• Domestic cultivation base: Chinese producers cultivate Haematococcus pluvialis across inland regions (Yunnan, Hubei/Jingzhou) and are scaling natural-astaxanthin capacity for both nutraceutical and aquaculture-feed-pigment use.
• Regulatory frame: dietary-supplement and feed-additive oversight sits with China’s market-regulation and agriculture authorities, framing the domestic carotenoid ingredient trade.
• Caveat: company-specific 2026 facts for Yunnan Alphy Biotech and Jingzhou-region producers returned only off-target or generic results in the capped search; this block intentionally carries no unconfirmed firm.

04EU#

Europe pairs an Austrian astaxanthin producer with an Icelandic leader to form the continent’s dedicated natural-carotenoid supply base, extended by the French Solabia Group’s Israeli desert-cultivation arm.

BDI-BioLife Science Austria, Algalíf Iceland, Solabia-Algatech, EU Novel Food#

• BDI-BioLife Science (Austria): produces ASTAFIT® astaxanthin from Haematococcus pluvialis under its “Red Diamond®” seal of quality for astaxanthin “Made in Austria” (food and supplement lines); the parent BDI-BioEnergy International was acquired in 2024 by EOSS Industries, Kanzler Verfahrenstechnik and the Rieckermann Group.
• Algalíf (Iceland): a global leader in sustainable natural astaxanthin cultivating under Iceland’s geothermal energy; its Astalíf™ oleoresin runs at 5%, 10%, 15% and 20% astaxanthin, including the world’s first 15% oleoresin and the April-2026 Astalíf™ 20 high-concentration benchmark.
• Solabia-Algatech (Kibbutz Ketura, Israel — Solabia Group, France): cultivates Haematococcus pluvialis in closed photobioreactors under Arava desert sunlight for its AstaPure® astaxanthin line, sold as oleoresin, a 3% whole-algae powder and finished gummy formats, alongside BioGlena® Euglena beta-glucan.
• EU Novel Food & EFSA: microalgae carotenoid ingredients in the EU are placed under the Novel Food framework and EFSA health-claim rules, shaping the European supplement ingredient market.

05Leading companies and research institutes#

06Tech stack and innovations#

The stack pairs two-stage microalgae cultivation with solvent-free extraction and high-concentration oleoresin standardization.

1. Two-stage Haematococcus cultivation (Two-Stage Haematococcus Cultivation):
   • Haematococcus pluvialis is grown as green motile cells for biomass, then shifted to nitrogen-starvation and high light to induce the red resting cyst that accumulates astaxanthin.
   • Cyanotech (Hawaii), BDI-BioLife (Austria) and Algalíf (Iceland) each run their own controlled-cultivation geometry (open raceways, closed photobioreactors) for reproducible carotenoid content.
2. Supercritical CO₂ extraction (Supercritical CO₂ Extraction):
   • Harvested red biomass is dewatered, cell walls are disrupted, and carotenoids are recovered with supercritical CO₂ to a solvent-free food-grade oleoresin.
   • The output is a standardized astaxanthin oleoresin that downstream brands formulate into softgels and gummies (e.g. Cyanotech’s 12 mg-per-serving BioAstin gummy).
3. High-concentration oleoresin formulation (Astaxanthin Oleoresin):
   • Algalíf’s Astalíf™ line is standardized to 5%, 10%, 15% and 20% astaxanthin, setting successive concentration benchmarks (world’s first 15% oleoresin; Astalíf™ 20 launched April 2026).

07Value chains and production pipelines#

Industrial pipeline of microalgal carotenoids (FDA DSHEA / EU Novel Food / ISO 22000)#

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Strain & inoculum      │ ───> │ 2. Green-cell cultivation │
└───────────────────────────┘      └───────────────────────────┘
                                                  │
                                                  ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Harvest & disruption   │ <─── │ 3. Stress induction       │
└───────────────────────────┘      └───────────────────────────┘
               │
               ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Supercritical CO₂      │ ───> │ 6. Oleoresin formulation  │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Strain & inoculum

An axenic Haematococcus pluvialis (or Dunaliella salina) master culture is scaled up under sterile conditions to a clean inoculum; the output is a ready-to-scale seed culture.

Stage 2: Green-cell cultivation

The inoculum is grown in closed photobioreactors or open raceways (Cyanotech’s 96-acre Kona farm, Iceland geothermal facilities) to build green vegetative biomass using CO₂ and sunlight; the output is concentrated green biomass.

Stage 3: Stress induction

Nitrogen starvation combined with high irradiance shifts the culture into the red resting-cyst stage, biosynthesizing and accumulating astaxanthin; the output is red cyst biomass rich in carotenoids.

Stage 4: Harvest & disruption

The red biomass is dewatered (centrifugation) and the tough cyst cell walls are mechanically disrupted to expose the carotenoid-rich interior; the output is disrupted cell paste.

Stage 5: Supercritical CO₂ extraction

Carotenoids are recovered from the paste with supercritical CO₂ under food-grade conditions to a solvent-free crude oleoresin; the output is natural astaxanthin oleoresin.

Stage 6: Oleoresin formulation

The crude oleoresin is standardized to 5%, 10%, 15% or 20% astaxanthin (Algalíf Astalíf™) and formulated into B2B ingredients and finished supplements (softgels, gummies) under FDA DSHEA / EU Novel Food / ISO 22000 controls; the output is a marketable microalgal carotenoid product.